Resources

To evaluate tapering of stable long-term opioid therapy (LTOT) and subsequent health care service use and chronic condition care.

This paper describes and compiles strategy selection and examines two hypotheses: 1) Overdose Education and Naloxone Distribution (OEND) selections will differ significantly between communities wit

The Jackson severe injection drug use-related infection (SIRI) team was developed as an integrated infectious disease/SUD treatment intervention for patients hospitalized at a public safety-net hos

This study aimed to understand stakeholder and provider perspectives on injectable opioid agonist treatment (iOAT) care and how it can be improved to better meet service users’ needs.

People with OUD involved in the criminal legal system are a vulnerable population, yet little research has comprehensively examined post-release outcomes associated with receiving MOUDs in jail and

This study aimed to longitudinally investigate incidence and predictors of first nonfatal overdose among women sex workers who use drugs.

We conducted a realist review of the literature to identify program theories that would explain successful and unsuccessful outcomes from residential treatment for SUD

We examined drug use practices, connectedness to other people who inject drugs, peer-to-peer injecting, and access to care among men who inject drugs in Melbourne, Australia.

We explored public support for safer supply programs in Saskatchewan and Alberta and identified predictors of support for this policy option.

We explore individual-level, network-level, and community-level characteristics associated with MOUD uptake in young people who inject drugs and their support network members.

The objective of our study was to explore mental health clinician attitudes towards substance use and associations with clinical experience and education level

In examining past policies, practices, and discourse that support heroin regulation and drug prohibition, the drivers of the current illegal drug overdose death epidemic in Canada are brought more

We explored the likelihood of securing a new primary care provider (PCP) among people with varying histories of opioid use who had recently lost access to their PCP.

This article examines how clinics’ take-home dosing policies have affected patients’ experiences of treatment and lives in general.

This study evaluated how telemedicine as a modality for opioid agonist treatment compares to in-person care

To investigate excess costs of buprenorphine-naloxone due to unmerited market exclusivity (no legal patent or data protection) in Canada.